INDAPAMIDE WATSON indapamide hemihydrate 2.5mg sugar coated tablet bottle

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

indapamide hemihydrate, Quantity: 2.5 mg

Commercializzato da:

Medis Pharma Pty Ltd

INN (Nome Internazionale):

indapamide hemihydrate

Forma farmaceutica:

Tablet, sugar coated

Composizione:

Excipient Ingredients: lactose monohydrate; maize starch; magnesium stearate; povidone; purified talc; calcium carbonate; titanium dioxide; sucrose; Acacia; ethyl acetate; purified water; stearic acid; industrial methylated spirit; polyvinyl acetate phthalate; Shellac; white beeswax; Carnauba Wax

Via di somministrazione:

Oral

Confezione:

60 tablets, 90 tablets

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

Management of essential hypertension. It may be tried as the sole therapeutic agent in the treatment of mild to moderate hypertension. Normally indapamide is used as the initial agent in multiple drug regimens.

Dettagli prodotto:

Visual Identification: White, biconvex, sugar coated tablets.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2012-04-05